These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7836063)

  • 1. A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide.
    Max H; Halder T; Kalbus M; Gnau V; Jung G; Kalbacher H
    Hum Immunol; 1994 Sep; 41(1):39-45. PubMed ID: 7836063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin.
    Verreck FA; Elferink D; Vermeulen CJ; Amons R; Breedveld F; de Vries RR; Koning F
    Tissue Antigens; 1995 Apr; 45(4):270-5. PubMed ID: 7638864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological cross-reactivity between a human Ro/SS-A autoantigen (calreticulin) and the lambda Ral-1 antigen of Onchocerca volvulus.
    Lux FA; McCauliffe DP; Büttner DW; Lucius R; Capra JD; Sontheimer RD; Lieu TS
    J Clin Invest; 1992 Jun; 89(6):1945-51. PubMed ID: 1602002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the autoantigen calreticulin.
    Rokeach LA; Haselby JA; Meilof JF; Smeenk RJ; Unnasch TR; Greene BM; Hoch SO
    J Immunol; 1991 Nov; 147(9):3031-9. PubMed ID: 1919005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
    Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
    Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calreticulin--the potential autoantigen in celiac disease.
    Karská K; Tucková L; Steiner L; Tlaskalová-Hogenová H; Michalak M
    Biochem Biophys Res Commun; 1995 Apr; 209(2):597-605. PubMed ID: 7733929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule".
    McCauliffe DP; Zappi E; Lieu TS; Michalak M; Sontheimer RD; Capra JD
    J Clin Invest; 1990 Jul; 86(1):332-5. PubMed ID: 2365822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calreticulin: not just another calcium-binding protein.
    Nash PD; Opas M; Michalak M
    Mol Cell Biochem; 1994 Jun; 135(1):71-8. PubMed ID: 7816058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interaction of a polypeptide homologous to human Ro/SS-A antigen (calreticulin) with a highly conserved amino acid sequence in the cytoplasmic domain of integrin alpha subunits.
    Rojiani MV; Finlay BB; Gray V; Dedhar S
    Biochemistry; 1991 Oct; 30(41):9859-66. PubMed ID: 1911778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of calreticulin in systemic lupus erythematosus.
    Eggleton P; Reid KB; Kishore U; Sontheimer RD
    Lupus; 1997; 6(7):564-71. PubMed ID: 9302659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a calreticulin-binding nuclear protein as histone (H1), an autoantigen in systemic lupus erythematosus.
    Treves S; Bajocchi G; Zorzato F; Govoni M; Trotta F
    Lupus; 1998; 7(7):479-87. PubMed ID: 9796851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calreticulin recognizes misfolded HLA-A2 heavy chains.
    Mancino L; Rizvi SM; Lapinski PE; Raghavan M
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5931-6. PubMed ID: 11983893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of endogenous peptides extracted from HLA-DR isolated from the spleen of a patient with rheumatoid arthritis.
    Gordon RD; Young JA; Rayner S; Luke RW; Crowther ML; Wordsworth P; Bell J; Hassall G; Evans J; Hinchliffe SA
    Eur J Immunol; 1995 May; 25(5):1473-6. PubMed ID: 7539763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three different forms of HLA-DR4Dw4 proteins.
    Buelow R; Paborsky LR; van Schooten WC; Kummerehl TJ; Schreifels R; Marshall K; Mayer J; Rothbard JB
    Eur J Immunol; 1993 Jan; 23(1):69-76. PubMed ID: 8419190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization.
    Eggleton P; Ward FJ; Johnson S; Khamashta MA; Hughes GR; Hajela VA; Michalak M; Corbett EF; Staines NA; Reid KB
    Clin Exp Immunol; 2000 May; 120(2):384-91. PubMed ID: 10792392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major retinal cell components recognized by onchocerciasis sera are associated with the cell surface and nucleoli.
    Zhou Y; Dziak E; Unnasch TR; Opas M
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1089-99. PubMed ID: 7510272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent structure of bovine brain calreticulin.
    Matsuoka K; Seta K; Yamakawa Y; Okuyama T; Shinoda T; Isobe T
    Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):435-42. PubMed ID: 8135753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide binding to soluble HLA-DR4 molecules produced by insect cells.
    Scheirle A; Takacs B; Kremer L; Marin F; Sinigaglia F
    J Immunol; 1992 Sep; 149(6):1994-9. PubMed ID: 1387668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex.
    Kosmopoulou A; Vlassi M; Stavrakoudis A; Sakarellos C; Sakarellos-Daitsiotis M
    J Comput Chem; 2006 Jul; 27(9):1033-44. PubMed ID: 16639700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
    Nair S; Wearsch PA; Mitchell DA; Wassenberg JJ; Gilboa E; Nicchitta CV
    J Immunol; 1999 Jun; 162(11):6426-32. PubMed ID: 10352256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.